-
Something wrong with this record ?
Antibiotic consumption and its influence on the resistance in Enterobacteriaceae
MH. Sedláková, K. Urbánek, V. Vojtová, H. Suchánková, P. Imwensi, M. Kolář,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT14398
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
BioMedCentral
from 2008-12-01
BioMedCentral Open Access
from 2008
Directory of Open Access Journals
from 2008
Free Medical Journals
from 2008
PubMed Central
from 2008
Europe PubMed Central
from 2008
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2008-01-01
Open Access Digital Library
from 2008-01-01
Medline Complete (EBSCOhost)
from 2009-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2008
Springer Nature OA/Free Journals
from 2008-12-01
- MeSH
- Aminoglycosides therapeutic use MeSH
- Anti-Bacterial Agents therapeutic use MeSH
- beta-Lactams therapeutic use MeSH
- Enterobacter cloacae drug effects isolation & purification physiology MeSH
- Enterobacteriaceae Infections drug therapy microbiology MeSH
- Escherichia coli drug effects isolation & purification physiology MeSH
- Fluoroquinolones therapeutic use MeSH
- Klebsiella pneumoniae drug effects isolation & purification physiology MeSH
- Humans MeSH
- Linear Models MeSH
- Microbial Sensitivity Tests MeSH
- Drug Resistance, Multiple, Bacterial drug effects MeSH
- Proteus mirabilis drug effects isolation & purification physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Increasing bacterial resistance to antibiotics is one of the most serious problems in current medicine. An important factor contributing to the growing prevalence of multiresistant bacteria is application of antibiotics. This study aimed at analyzing the development of resistance of Enterobacteriaceae to selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the University Hospital Olomouc and assessing the effect of selection pressure of these antibiotics. METHODS: For the period between 1 January 2000 and 31 December 2011, resistance of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Proteus mirabilis to third- and fourth-generation cephalosporins, meropenem, piperacillin/tazobactam, fluoroquinolones and aminoglycosides was retrospectively studied. For the assessment of selection pressure of antibiotics, a parameter of defined daily dose in absolute annual consumption (DDDatb) based on the ATC/DDD classification and in relative annual consumption (RDDDatb) as the number of defined daily doses per 100 bed-days was used. The relationship between frequency of strains resistant to a particular antibiotic and antibiotic consumption was assessed by linear regression analysis using Spearman's correlation. The level of statistical significance was set at p < 0.05. RESULTS: A total of 113,027 isolates from the Enterobacteriaceae family were analyzed. There was a significant effect of selection pressure of the primary antibiotic in the following cases: piperacillin/tazobactam in Klebsiella pneumoniae, gentamicin in Klebsiella pneumoniae and Escherichia coli and amikacin in Escherichia coli and Enterobacter cloacae. Also, there was significant correlation between resistance to ceftazidime and consumption of piperacillin/tazobactam in Klebsiella pneumoniae and Escherichia coli. No relationship was found between consumption of third- and fourth-generation cephalosporins and resistance to ceftazidime or between fluoroquinolone consumption and resistance to ciprofloxacin. CONCLUSION: The study showed the effects of both direct and indirect selection pressure on increasing resistance to gentamicin, amikacin, piperacillin/tazobactam and ceftazidime. Given the fact that no correlation was found between resistance to fluoroquinolones and consumption of either primary or secondary antibiotics, we assume that the increasing resistance to fluoroquinolones is probably due to circulation of resistance genes in the bacterial population and that this resistance was not affected by reduced use of these antibiotics.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014137
- 003
- CZ-PrNML
- 005
- 20190902152557.0
- 007
- ta
- 008
- 150420s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1756-0500-7-454 $2 doi
- 035 __
- $a (PubMed)25027417
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Htoutou Sedláková, Miroslava $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic. miroslava.htoutou@seznam.cz. $7 xx0134388
- 245 10
- $a Antibiotic consumption and its influence on the resistance in Enterobacteriaceae / $c MH. Sedláková, K. Urbánek, V. Vojtová, H. Suchánková, P. Imwensi, M. Kolář,
- 520 9_
- $a BACKGROUND: Increasing bacterial resistance to antibiotics is one of the most serious problems in current medicine. An important factor contributing to the growing prevalence of multiresistant bacteria is application of antibiotics. This study aimed at analyzing the development of resistance of Enterobacteriaceae to selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the University Hospital Olomouc and assessing the effect of selection pressure of these antibiotics. METHODS: For the period between 1 January 2000 and 31 December 2011, resistance of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Proteus mirabilis to third- and fourth-generation cephalosporins, meropenem, piperacillin/tazobactam, fluoroquinolones and aminoglycosides was retrospectively studied. For the assessment of selection pressure of antibiotics, a parameter of defined daily dose in absolute annual consumption (DDDatb) based on the ATC/DDD classification and in relative annual consumption (RDDDatb) as the number of defined daily doses per 100 bed-days was used. The relationship between frequency of strains resistant to a particular antibiotic and antibiotic consumption was assessed by linear regression analysis using Spearman's correlation. The level of statistical significance was set at p < 0.05. RESULTS: A total of 113,027 isolates from the Enterobacteriaceae family were analyzed. There was a significant effect of selection pressure of the primary antibiotic in the following cases: piperacillin/tazobactam in Klebsiella pneumoniae, gentamicin in Klebsiella pneumoniae and Escherichia coli and amikacin in Escherichia coli and Enterobacter cloacae. Also, there was significant correlation between resistance to ceftazidime and consumption of piperacillin/tazobactam in Klebsiella pneumoniae and Escherichia coli. No relationship was found between consumption of third- and fourth-generation cephalosporins and resistance to ceftazidime or between fluoroquinolone consumption and resistance to ciprofloxacin. CONCLUSION: The study showed the effects of both direct and indirect selection pressure on increasing resistance to gentamicin, amikacin, piperacillin/tazobactam and ceftazidime. Given the fact that no correlation was found between resistance to fluoroquinolones and consumption of either primary or secondary antibiotics, we assume that the increasing resistance to fluoroquinolones is probably due to circulation of resistance genes in the bacterial population and that this resistance was not affected by reduced use of these antibiotics.
- 650 _2
- $a aminoglykosidy $x terapeutické užití $7 D000617
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a mnohočetná bakteriální léková rezistence $x účinky léků $7 D024901
- 650 _2
- $a Enterobacter cloacae $x účinky léků $x izolace a purifikace $x fyziologie $7 D016972
- 650 _2
- $a enterobakteriální infekce $x farmakoterapie $x mikrobiologie $7 D004756
- 650 _2
- $a Escherichia coli $x účinky léků $x izolace a purifikace $x fyziologie $7 D004926
- 650 _2
- $a fluorochinolony $x terapeutické užití $7 D024841
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Klebsiella pneumoniae $x účinky léků $x izolace a purifikace $x fyziologie $7 D007711
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a Proteus mirabilis $x účinky léků $x izolace a purifikace $x fyziologie $7 D011513
- 650 _2
- $a beta-laktamy $x terapeutické užití $7 D047090
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Urbánek, Karel, $d 1969- $7 xx0078289
- 700 1_
- $a Vojtová, Vladimíra $7 xx0301884
- 700 1_
- $a Jurečková, Hana $7 xx0250629
- 700 1_
- $a Imwensi, Peter $7 _AN074508
- 700 1_
- $a Kolář, Milan, $d 1964- $7 jn20010310083
- 773 0_
- $w MED00165970 $t BMC research notes $x 1756-0500 $g Roč. 7, č. - (2014), s. 454
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25027417 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20190902152926 $b ABA008
- 999 __
- $a ok $b bmc $g 1071718 $s 897015
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 7 $c - $d 454 $i 1756-0500 $m BMC research notes $n BMC Res Notes $x MED00165970
- GRA __
- $a NT14398 $p MZ0
- LZP __
- $a Pubmed-20150420